223 related articles for article (PubMed ID: 34099636)
21. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
22. Activation of signal transducer and activator of transcription 5 (STAT5) is linked to β1-integrin protein abundance in unilaterally milked bovine mammary glands.
Murney R; Stelwagen K; Wheeler TT; Margerison JK; Singh K
J Dairy Sci; 2015 May; 98(5):3133-42. PubMed ID: 25771047
[TBL] [Abstract][Full Text] [Related]
23. Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis.
Caffarel MM; Zaragoza R; Pensa S; Li J; Green AR; Watson CJ
Cell Death Differ; 2012 Mar; 19(3):511-22. PubMed ID: 21941370
[TBL] [Abstract][Full Text] [Related]
24. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
Peng M; Ball-Kell SM; Tyner AL
Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
[TBL] [Abstract][Full Text] [Related]
25. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
[TBL] [Abstract][Full Text] [Related]
27. Prolactin promotes mammary pathogenesis independently from cyclin D1.
Asher JM; O'Leary KA; Rugowski DE; Arendt LM; Schuler LA
Am J Pathol; 2012 Jul; 181(1):294-302. PubMed ID: 22658484
[TBL] [Abstract][Full Text] [Related]
28. CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy.
Mapes J; Li Q; Kannan A; Anandan L; Laws M; Lydon JP; Bagchi IC; Bagchi MK
PLoS Genet; 2017 Mar; 13(3):e1006654. PubMed ID: 28278176
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
[TBL] [Abstract][Full Text] [Related]
30. PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development.
Chan CB; Liu X; Ensslin MA; Dillehay DL; Ormandy CJ; Sohn P; Serra R; Ye K
EMBO J; 2010 Mar; 29(5):956-68. PubMed ID: 20075866
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
[TBL] [Abstract][Full Text] [Related]
32. In vivo study of prolactin (PRL) intracellular signalling during lactogenesis in the rat: JAK/STAT pathway is activated by PRL in the mammary gland but not in the liver.
Jahn GA; Daniel N; Jolivet G; Belair L; Bole-Feysot C; Kelly PA; Djiane J
Biol Reprod; 1997 Oct; 57(4):894-900. PubMed ID: 9314595
[TBL] [Abstract][Full Text] [Related]
33. H2AX Promoter Demethylation at Specific Sites Plays a Role in STAT5-Induced Tumorigenesis.
Havusha-Laufer S; Kosenko A; Kisliouk T; Barash I
J Mammary Gland Biol Neoplasia; 2020 Sep; 25(3):205-218. PubMed ID: 32748326
[TBL] [Abstract][Full Text] [Related]
34. Lactation failure in Src knockout mice is due to impaired secretory activation.
Watkin H; Richert MM; Lewis A; Terrell K; McManaman JP; Anderson SM
BMC Dev Biol; 2008 Jan; 8():6. PubMed ID: 18215306
[TBL] [Abstract][Full Text] [Related]
35. Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas.
O'Leary KA; Rugowski DE; Sullivan R; Schuler LA
Oncogene; 2014 Jun; 33(23):3075-82. PubMed ID: 23873024
[TBL] [Abstract][Full Text] [Related]
36. Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice.
Wu Y; Kim J; Elshimali Y; Sarkissyan M; Vadgama JV
BMC Cancer; 2014 Apr; 14():266. PubMed ID: 24742286
[TBL] [Abstract][Full Text] [Related]
37. Tumors caused by overexpression and forced activation of Stat5 in mammary epithelial cells of transgenic mice are parity-dependent and developed in aged, postestropausal females.
Eilon T; Groner B; Barash I
Int J Cancer; 2007 Nov; 121(9):1892-1902. PubMed ID: 17640063
[TBL] [Abstract][Full Text] [Related]
38. Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland.
Volker SE; Hedrick SE; Feeney YB; Clevenger CV
Cancer Res; 2018 Jul; 78(14):3877-3887. PubMed ID: 29959151
[TBL] [Abstract][Full Text] [Related]
39. SnoN regulates mammary gland alveologenesis and onset of lactation by promoting prolactin/Stat5 signaling.
Jahchan NS; Wang D; Bissell MJ; Luo K
Development; 2012 Sep; 139(17):3147-56. PubMed ID: 22833129
[TBL] [Abstract][Full Text] [Related]
40. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
